PIONEERING HEALTHCARE FOR THE HUMAN RACE

EmtrixTM, the leading treatment for patients suffering from nail fungus and nail psoriasis, will be licensed by Mundipharma from the Swedish pharmaceutical company and to be marketed as part of the...

Nasal and ear sprays and decongestants will be available to patients aged 6 months to 10 years across Middle East, Turkey and Africa. XX August, Dubai: Mundipharma’s commitment to tackling some...

A unique non-estrogen prescription therapy, Intrarosa™, has been approved by the US Food and Drug Administration (FDA) and by the European Medical Agency (EMA), for the treatment of the most...

Mundipharma to be Gold sponsor of 8th annual EROC, held at InterContinental Hotel in Dubai Festival City. Three-day event will feature healthcare leaders from across the world. Dubai, January 17,...

Mundipharma, leading healthcare organization, whose BETADINE® range is the ‘Official Healthcare Product Partner’ of English Premier League giants Manchester City will co-host a highly anticipated...

Leading International Pharmaceutical company Mundipharma, celebrated World Glaucoma Week earlier in March in partnership with ophthalmology community and authorities by taking action to encourage...